Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8.34M | $11.0M | 21.53% | -- | 2026-03-31 |
| Sands Capital Alternatives, LLC | 2.12M | $2.0M | 5.48% | -- | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 888.1K | $1.0M | 2.29% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 758.4K | $1.0M | 1.96% | +124.3K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 722.0K | $1.0M | 1.86% | -- | 2026-03-31 |
| MARSHALL WACE, LLP | 560.4K | -- | 1.45% | +64.4K | 2026-03-31 |
| JANE STREET GROUP, LLC | 239.7K | -- | 0.62% | -102.4K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 236.4K | -- | 0.61% | +38.2K | 2026-03-31 |
| BlackRock, Inc. | 208.9K | -- | 0.54% | +3.8K | 2026-03-31 |
| GSA CAPITAL PARTNERS LLP | 186.7K | -- | 0.48% | -- | 2026-03-31 |
